ACTO Named Among Everest Group's Top 50™ Pharmaceutical Technology Providers for 2026
Recognition underscores ACTO's leadership in AI-powered field excellence and agentic AI purpose-built for Life Sciences TORONTO and NEW YORK, Sept. 14, 2026 /PRNewswire/ -- ACTO, uniting human intelligence with empathetic AI in Life Sciences, today announced its inclusion in Everest...
Covered in this story
What has happened since
- Everest Group is up 5.0% since this was published, 40 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $EG yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Everest Group →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.